rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Hugh M. Cole

Director

Company insider

Files Form 4 as: Director, Astria Therapeutics; Chief Operating Officer, Jounce Therapeutics; SVP, Chief Business Officer, Ariad Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
79
Buys
1
Sells
15
Bought
$15K
Sold
$425K
Companies
3
Companies where not an officer
1
First trade
25 Jun 2014
Last trade
23 Jan 2026
Last filed
23 Jan 2026

Companies traded

Where they are an officer
Jounce TherapeuticsOfficer · last 10 Jan 20231 buy · 14 sells
Ariad PharmaceuticalsOfficer · last 16 Feb 20170 buys · 1 sell
Everywhere else they filed: board seats, 10% stakes, other companies
Astria TherapeuticsDirector · Biotechnology · last 23 Jan 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—16,666filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—8,333filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—14,100filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivativeSEC FORM 4 Code D—16,666filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivativeSEC FORM 4 Code D—8,333filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivativeSEC FORM 4 Code D—14,100filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivativeSEC FORM 4 Code D—14,100filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivativeSEC FORM 4 Code D—26,550filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—14,100filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—26,550filing
11 Jun 2025filed 12 Jun 2025Astria Therapeuticsoption or derivativeSEC FORM 4 Code A—26,550 at $0.00filing
5 Jun 2024filed 6 Jun 2024Astria Therapeuticsoption or derivativeSEC FORM 4 Code A—14,100 at $0.00filing
2 Jun 2023filed 6 Jun 2023Astria Therapeuticsoption or derivativeSEC FORM 4 Code A—14,100 at $0.00filing
10 Jan 2023filed 11 Jan 2023Jounce TherapeuticsSEC FORM 4 Sold$10K9,182 at $1.12filing
9 Jan 2023filed 11 Jan 2023Jounce TherapeuticsSEC FORM 4 Sold$8,1977,452 at $1.10filing
1 Aug 2022filed 3 Aug 2022Jounce Therapeuticsoption or derivativeSEC FORM 4 Code A—40,000 at $0.00filing
1 Aug 2022filed 3 Aug 2022Jounce TherapeuticsSEC FORM 4 Code A—20,000 at $0.00filing
9 Jun 2022filed 21 Jun 2022Astria Therapeuticsoption or derivativeSEC FORM 4 Code A—8,333 at $0.00filing
9 Jun 2022filed 9 Jun 2022Astria Therapeuticsoption or derivativeSEC FORM 4 Code A—8,333 at $0.00filing
1 Feb 2022filed 17 Mar 2022Jounce Therapeuticsoption or derivativeSEC FORM 4 Code A—85,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed16

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.